Beijing Chunlizhengda Medical Instruments Co Ltd (688236) - Total Assets
Based on the latest financial reports, Beijing Chunlizhengda Medical Instruments Co Ltd (688236) holds total assets worth CN¥3.54 Billion CNY (≈ $518.06 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Beijing Chunlizhengda Medical Instrument cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Beijing Chunlizhengda Medical Instruments Co Ltd - Total Assets Trend (2012–2024)
This chart illustrates how Beijing Chunlizhengda Medical Instruments Co Ltd's total assets have evolved over time, based on quarterly financial data. See Beijing Chunlizhengda Medical Instrument net assets for net asset value and shareholders' equity analysis.
Beijing Chunlizhengda Medical Instruments Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Beijing Chunlizhengda Medical Instruments Co Ltd's total assets of CN¥3.54 Billion consist of 82.0% current assets and 18.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 32.9% |
| Accounts Receivable | CN¥381.12 Million | 11.0% |
| Inventory | CN¥550.84 Million | 15.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥127.57 Million | 3.7% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Beijing Chunlizhengda Medical Instruments Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Beijing Chunlizhengda Medical Instrument market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beijing Chunlizhengda Medical Instruments Co Ltd's current assets represent 82.0% of total assets in 2024, an increase from 64.4% in 2012.
- Cash Position: Cash and equivalents constituted 32.9% of total assets in 2024, up from 0.0% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 19.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 15.9% of total assets.
Beijing Chunlizhengda Medical Instruments Co Ltd Competitors by Total Assets
Key competitors of Beijing Chunlizhengda Medical Instruments Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM
|
USA | $101.85 Million |
|
Allmed Solutions Ltd
TA:ALMD
|
Israel | ILA31.54 Million |
|
Universal Biosensors Inc
AU:UBI
|
Australia | AU$14.94 Million |
Beijing Chunlizhengda Medical Instruments Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.33 | 4.76 | 3.39 |
| Quick Ratio | 5.09 | 3.80 | 2.94 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.44 Billion | CN¥2.26 Billion | CN¥883.15 Million |
Beijing Chunlizhengda Medical Instruments Co Ltd - Advanced Valuation Insights
This section examines the relationship between Beijing Chunlizhengda Medical Instruments Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.85 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -5.0% |
| Total Assets | CN¥3.47 Billion |
| Market Capitalization | $611.59 Million USD |
Valuation Analysis
Below Book Valuation: The market values Beijing Chunlizhengda Medical Instruments Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Beijing Chunlizhengda Medical Instruments Co Ltd's assets decreased by 5.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2024)
The table below shows the annual total assets of Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.47 Billion ≈ $507.15 Million |
-5.04% |
| 2023-12-31 | CN¥3.65 Billion ≈ $534.05 Million |
+7.03% |
| 2022-12-31 | CN¥3.41 Billion ≈ $498.96 Million |
+13.67% |
| 2021-12-31 | CN¥3.00 Billion ≈ $438.94 Million |
+94.78% |
| 2020-12-31 | CN¥1.54 Billion ≈ $225.35 Million |
+27.34% |
| 2019-12-31 | CN¥1.21 Billion ≈ $176.96 Million |
+48.43% |
| 2018-12-31 | CN¥814.74 Million ≈ $119.22 Million |
+28.58% |
| 2017-12-31 | CN¥633.66 Million ≈ $92.72 Million |
+17.32% |
| 2016-12-31 | CN¥540.13 Million ≈ $79.04 Million |
+12.99% |
| 2015-12-31 | CN¥478.04 Million ≈ $69.95 Million |
+99.30% |
| 2014-12-31 | CN¥239.86 Million ≈ $35.10 Million |
+19.55% |
| 2013-12-31 | CN¥200.63 Million ≈ $29.36 Million |
+7.00% |
| 2012-12-31 | CN¥187.51 Million ≈ $27.44 Million |
-- |
About Beijing Chunlizhengda Medical Instruments Co Ltd
Beijing Chunlizhengda Medical Instruments Co., Ltd. engages in the research and development, production, and trading of surgical implants, instruments, and related products in the People's Republic of China. The company offers implantable orthopedic medical devices, joints, dentures, spine, sports medicine, trauma and orthopedic surgical instruments. It sells its products through distributors, or… Read more